InsidersTradesSigma
Follow the CSPC Pharmaceutical Group Ltd. share price and the full directors' dealings record of the company, a publicly traded company based in Hong Kong. Shares are quoted on the HK market, under the supervision of HKEX. Operating in the Health Care sector, CSPC Pharmaceutical Group Ltd. has logged 6 public disclosures. Market capitalisation: €97.4bn. The latest transaction was disclosed on 29 June 2026 (Sale). Among the most active insiders: Cai Dong Chen. The full history is free.
Analysts rate CSPC Pharmaceutical Group Ltd. Buy (bullish), based on 21 analysts. Average price target: HK$11.47.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
石药集团有限公司是一家中国制药公司，从事药品的研发、制造和销售。该公司在香港证券交易所上市，股票代码为XHKG。